Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer

被引:91
作者
Buisseret, Laurence [1 ,2 ,3 ]
Desmedt, Christine [2 ]
Garaud, Soizic [1 ]
Fornili, Marco [4 ]
Wang, Xiaoxiao [1 ,2 ,3 ]
Van den Eyden, Gert [5 ]
de Wind, Alexandre [6 ]
Duquenne, Sebastien [6 ,8 ]
Boisson, Anais [1 ]
Naveaux, Celine [1 ]
Rothe, Francoise [2 ]
Rorive, Sandrine [7 ]
Decaestecker, Christine [7 ]
Larsimont, Denis [6 ]
Piccart-Gebhart, Martine [3 ]
Biganzoli, Elia [4 ]
Sotiriou, Christos [2 ,3 ]
Willard-Gallo, Karen [1 ]
机构
[1] Univ Libre Bruxelles, Inst Jules Bordet, Mol Immunol Unit, 121 Blvd Waterloo, B-1000 Brussels, Belgium
[2] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium
[3] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Brussels, Belgium
[4] Univ Milan, Dept Clin Sci & Community Hlth, Unit Med Stat Biometry & Bioinformat Giulio A Mac, Fdn IRCCS Ist Nazl Tumori, Campus Cascina Rosa, Milan, Italy
[5] GZA Ziekenhuizen, Dept Pathol, Sint Augustinus Campus, Antwerp, Belgium
[6] Univ Libre Bruxelles, Inst Jules Bordet, Dept Pathol, Brussels, Belgium
[7] Ctr Microscopy & Mol Imaging, Gosselies, Belgium
[8] Ctr Hosp Univ la Reunion, Dept Pathol, St Pierre, Reunion, France
关键词
PROGNOSTIC-SIGNIFICANCE; CHEMOTHERAPY; AGREEMENT;
D O I
10.1038/modpathol.2017.43
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The presence of tumor-infiltrating lymphocytes (TIL), reflecting host immune activity, is frequently correlated with better clinical outcomes, particularly in HER2-positive and triple-negative breast cancer. Recent findings suggest that organization of immune infiltrates in tertiary lymphoid structures also has a beneficial effect on survival. This study investigated inter-and intra-observer variation in TIL assessment using conventional hematoxylin-eosin versus immunohistochemical staining to identify immune cells. Global, intratumoral, and stromal TIL, as well as tertiary lymphoid structures were scored independently by experienced pathologists on full-face tumor sections (n = 124). The fidelity of scoring infiltrates in core biopsies compared to surgical specimens, and pathological assessment compared to quantitative digital analysis was also evaluated. The inter-observer concordance correlation coefficient was 0.80 for global, 0.72 for intratumoral, and 0.71 for stromal TIL, while the intra-observer concordance correlation coefficient was 0.90 for global, 0.77 for intratumoral, and 0.89 for stromal TIL using immunohistochemical stains. Correlations were lower with hematoxylin-eosin stains, particularly for intratumoral TIL, while global scores had the highest concordance correlation coefficients. Our study concluded that tertiary lymphoid structures are accurately and consistently scored using immunohistochemical but not hematoxylin-eosin stains. A strong association was observed between TIL in core biopsies and surgical samples (R-2 = 0.74) but this did not extend to tertiary lymphoid structures (R-2 = 0.26). TIL scored by pathologists and digital analysis were correlated but our analysis reveals a constant bias between these methods. These data challenge current criteria for TIL and tertiary lymphoid structure assessment in breast cancer and recommend that how pathologists evaluate immune infiltrates be reexamined for future studies.
引用
收藏
页码:1204 / 1212
页数:9
相关论文
共 24 条
  • [1] Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
    Adams, Sylvia
    Gray, Robert J.
    Demaria, Sandra
    Goldstein, Lori
    Perez, Edith A.
    Shulman, Lawrence N.
    Martino, Silvana
    Wang, Molin
    Jones, Vicky E.
    Saphner, Thomas J.
    Wolff, Antonio C.
    Wood, William C.
    Davidson, Nancy E.
    Sledge, George W.
    Sparano, Joseph A.
    Badve, Sunil S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) : 2959 - +
  • [2] Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer
    Ali, H. Raza
    Dariush, Aliakbar
    Provenzano, Elena
    Bardwell, Helen
    Abraham, Jean E.
    Iddawela, Mahesh
    Vallier, Anne-Laure
    Hiller, Louise
    Dunn, Janet. A.
    Bowden, Sarah J.
    Hickish, Tamas
    McAdam, Karen
    Houston, Stephen
    Irwin, Mike J.
    Pharoah, Paul D. P.
    Brenton, James D.
    Walton, Nicholas A.
    Earl, Helena M.
    Caldas, Carlos
    [J]. BREAST CANCER RESEARCH, 2016, 18
  • [3] Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival
    Beck, Andrew H.
    Sangoi, Ankur R.
    Leung, Samuel
    Marinelli, Robert J.
    Nielsen, Torsten O.
    van de Vijver, Marc J.
    West, Robert B.
    van de Rijn, Matt
    Koller, Daphne
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (108)
  • [4] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [5] Tumor-infiltrating lymphocyte composition, organization and PD-1/PD-L1 expression are linked in breast cancer
    Buisseret, Laurence
    Garaud, Soizic
    de Wind, Alexandre
    Van den Eynden, Gert
    Boisson, Anais
    Solinas, Cinzia
    Gu-Trantien, Chunyan
    Naveaux, Celine
    Lodewyckx, Jean-Nicolas
    Duvillier, Hugues
    Craciun, Ligia
    Veys, Isabelle
    Larsimont, Denis
    Piccart-Gebhart, Martine
    Stagg, John
    Sotiriou, Christos
    Willard-Gallo, Karen
    [J]. ONCOIMMUNOLOGY, 2017, 6 (01):
  • [6] DENKERT C, 2017, CANCER RES S4, V77
  • [7] Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group
    Denkert, Carsten
    Wienert, Stephan
    Poterie, Audrey
    Loibl, Sibylle
    Budczies, Jan
    Badve, Sunil
    Bago-Horvath, Zsuzsanna
    Bane, Anita
    Bedri, Shahinaz
    Brock, Jane
    Chmielik, Ewa
    Christgen, Matthias
    Colpaert, Cecile
    Demaria, Sandra
    Van den Eynden, Gert
    Floris, Giuseppe
    Fox, Stephen B.
    Gao, Dongxia
    Heppner, Barbara Ingold
    Kim, S. Rim
    Kos, Zuzana
    Kreipe, Hans H.
    Lakhani, Sunil R.
    Penault-Llorca, Frederique
    Pruneri, Giancarlo
    Radosevic-Robin, Nina
    Rimm, David L.
    Schnitt, Stuart J.
    Sinn, Bruno V.
    Sinn, Peter
    Sirtaine, Nicolas
    O'Toole, Sandra A.
    Viale, Giuseppe
    Van de Vijver, Koen
    de Wind, Roland
    von Minckwitz, Gunter
    Klauschen, Frederick
    Untch, Michael
    Fasching, Peter A.
    Reimer, Toralf
    Willard-Gallo, Karen
    Michiels, Stefan
    Loi, Sherene
    Salgado, Roberto
    [J]. MODERN PATHOLOGY, 2016, 29 (10) : 1155 - 1164
  • [8] Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
    Denkert, Carsten
    Loibl, Sibylle
    Noske, Aurelia
    Roller, Marc
    Mueller, Berit Maria
    Komor, Martina
    Budczies, Jan
    Darb-Esfahani, Silvia
    Kronenwett, Ralf
    Hanusch, Claus
    von Toerne, Christian
    Weichert, Wilko
    Engels, Knut
    Solbach, Christine
    Schrader, Iris
    Dietel, Manfred
    von Minckwitz, Gunter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 105 - 113
  • [9] Tertiary lymphoid structures in cancer and beyond
    Dieu-Nosjean, Marie-Caroline
    Goc, Jeremy
    Giraldo, Nicolas A.
    Sautes-Fridman, Catherine
    Fridman, Wolf Herman
    [J]. TRENDS IN IMMUNOLOGY, 2014, 35 (11) : 571 - 580
  • [10] Relevance of tumor-infiltrating lymphocytes in breast cancer
    Dushyanthen, Sathana
    Beavis, Paul A.
    Savas, Peter
    Teo, Zhi Ling
    Zhou, Chenhao
    Mansour, Mariam
    Darcy, Phillip K.
    Loi, Sherene
    [J]. BMC MEDICINE, 2015, 13